Business Daily Media

Business Marketing

.

Hua Medicine Announces the Drug Manufacturing Permit Granted for Dorzagliatin

  • Written by ACN Newswire - Press Releases
SHANGHAI, CHINA, Oct 14, 2020 - (ACN Newswire) - Hua Medicine (the "Company", Stock Code: 2552.HK) announces that, after review and on-site verification under the Marketing Authorization Holder ("MAH") system, the Company has obtained the drug manufacturing permit for dorzagliatin, its investigational first-in-class drug, issued by the Shanghai

Read more //?#

Popular

TaskPods

The New On-The-Go Workplaces of the Future  Australians now have access to on-the-go offices with the first of their kind ‘TaskPods’ being rolled out at busy shopping centres, airports and transport hubs across the country.  ...

Reasons To Hire A Right Personal Injury Lawyer

Unfortunately, you are reading this article probably because someone from your relatives, family, or you (maybe) have encountered an accident due to the reckless driving of some unknown fellow on the road. Well, you need not wor...

WSET Honours Australian Graduates and Award Winners

Over 500 of the most influential wine and spirits professionals in the world gathered on the evening of Monday 23 January at the historic Guildhall, City of London, to celebrate the annual Wine & Spirit Education Trust (WSET) ...